Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure.
Elham Shirazi-TehraniNegar FirouzabadiGholamhossein TamaddonEhsan BahramaliAsma VafadarPublished in: Pharmacogenomics and personalized medicine (2020)
In conclusion, it might be postulated that one of the mechanisms by which carvedilol may exert its cardioprotective effects can be through increasing miR-1 and miR-214 expressions which may also serve as a potential therapeutic target in patients with systolic HF in future.